高级检索
当前位置: 首页 > 详情页

T-Helper 17 Cell/Regulatory T-Cell Imbalance in COPD Combined with T2DM Patients

| 导出 | |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Second Department of Respiratory Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming,650032, People’s Republic of China [2]Department of Burns Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650101,People’s Republic of China [3]First Department of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, People’sRepublic of China
出处:
ISSN:

关键词: COPD combined with T2DM Th17/Treg cytokine transcription factor

摘要:
Background: Chronic obstructive pulmonary disease (COPD) is often combined with type 2 diabetes mellitus (T2DM) in clinical, and with poor prognosis. In recent years, research shows that inflammation is a common characteristic of COPD and T2DM. T-helper 17 cell (Th17)/regulatory T-cell (Treg) balance controls inflammation and may be important in the pathogenesis of COPD combined with T2DM patients. This study investigated the characteristics of Th17, Treg and related inflammatory factors in COPD combined with T2DM patients and the potential mechanism. Methods: Application of flow cytometry technology, real-time fluorescent quantitative PCR and ELISA to detect the changes in peripheral blood of Th17 and Treg number and the expression of key transcription factors and related cytokines in COPD combined T2DM patients were performed. Results: Patients with COPD combined with T2DM revealed significant increase in peripheral Th17, Th17 related cytokines (IL-17A, IL-17F, IL-21, IL-23, IL-6) and transcription factor (ROR gamma t) levels and significant decrease in Treg, Treg-related cytokines (IL-10, TGF beta 1) and transcription factor (Foxp3) as compared with patients with COPD, T2DM and healthy controls. Conclusion: Th17/Treg functional imbalance exists in patients with COPD combined with T2DM, indicating a potential role of Th17/Treg imbalance in the formation and progression of COPD combined with T2DM.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 3 区 医学
小类 | 3 区 呼吸系统
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 呼吸系统
JCR分区:
出版当年[2021]版:
Q3 RESPIRATORY SYSTEM
最新[2023]版:
Q2 RESPIRATORY SYSTEM

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Second Department of Respiratory Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming,650032, People’s Republic of China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:52538 今日访问量:0 总访问量:1562 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)